Explore Our Comprehensive Life Sciences Industry Research Reports
P
2023
The global biosimilar monoclonal antibody market was valued at $8.7 billion in 2022, and is projected to reach $64.7 billion by 2032, growing at a CAGR of 22.2% from 2023 to 2032.
Report Code : A03330 | Pages : 293 | Category : Life Sciences
P
2023
The global biosimilar testing and development services market was valued at $2.5 billion in 2022, and is projected to reach $7.8 billion by 2032, growing at a CAGR of 12.1% from 2023 to 2032.
Report Code : A03627 | Pages : 302 | Category : Life Sciences
U
2024
Report Code : A04504 | Category : Life Sciences
A
2024
The Generic and biosimilar pharmaceuticals market report outlines the current market analysis ...
Report Code : A195590 | Category : Life Sciences
P
2024
By component, the Pharmaceutical and Biopharmaceutical Companies was the dominant sub-segment with major market share in 2022 in the North America Biosimilar Testing and Development Services Market. This sub-segment is likely to follow same momentum by the end of 2032.
Report Code : A308933 | Pages : 130 | Category : Life Sciences
P
2024
Canada Biosimilar Testing and Development Services Market is projected to experience high investment on various major technologies/product/services in Canada country by the end of 2032 owing to presence of key end user vertical adopting offerings at a faster pace.
Report Code : A308934 | Pages : 81 | Category : Life Sciences
P
2024
The U.S. Biosimilar Testing and Development Services Market segment End User is expected to witness highest CAGR during the forecast period. The report provides insights about opportunities that would help the market to expand in future.
Report Code : A308935 | Pages : 84 | Category : Life Sciences
P
2024
The Mexico Biosimilar Testing and Development Services Market is expected to expand at a promising compound annual growth rate (CAGR) between 2023 to 2032. The Mexico Biosimilar Testing and Development Services Market growth is attributed to various driving factors and revenue opportunities.
Report Code : A308936 | Pages : 76 | Category : Life Sciences
P
2024
The Europe Biosimilar Testing and Development Services Market achieved significant revenue share in base year of analysis. The Europe Biosimilar Testing and Development Services Market size is expected to account for a considerable growth rate between 2023 to 2032.
Report Code : A308937 | Pages : 120 | Category : Life Sciences
P
2024
The Germany Biosimilar Testing and Development Services Market is expected to expand at a promising compound annual growth rate (CAGR) between 2023 to 2032. The Germany Biosimilar Testing and Development Services Market growth is attributed to various driving factors and revenue opportunities.
Report Code : A308938 | Pages : 77 | Category : Life Sciences
Register and Earn 500 Loyalty Points
An Email Verification Code has been sent to your email address!
Please check your inbox and, if you don't find it there, also look in your junk folder.